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doi:10.1016/j.ejvs.2008.12.010Abstract Objectives: To observe the clinical features and angiographic findings in patients
with a spontaneous isolated superior mesenteric artery dissection (SISMAD) and to identify
any correlation between them.
Methods: From a single institution, 32 patients (22 symptomatic patients at presentation;
mean age 54 years; men 97%) with SISMAD were retrospectively reviewed. All patients were
available for clinical follow-up after treatment (conservative, nZ 28, 88%, open or endovas-
cular superior mesenteric artery (SMA) reconstruction, nZ 4, 12%), and follow-up CT scans
were available in 28 patients (mean 22 months, range 1e80 months).
Results: We found a positive correlation between pain severity and dissection length
(pZ 0.03, rZ 0.50, Spearman’s partial correlation analysis). After conservative treatment,
only one patient (3%) required bowel resection, and there was no difference in outcome
between patients who were treated with anticoagulation or anti-platelet therapy and those
who were not (pZ 1.00, Fisher’s exact test). No patients had progression of their lesion on
the follow-up CT angiography.
Conclusions: In SISMAD patients, dissection length is positively associated with more severe
clinical symptoms. After conservative treatment, we observed a benign clinical course and
no CT progression of the dissection, even without anticoagulation or anti-platelet therapy.
Based on our observation, patients with SISMAD can be treated conservatively without antic-
oagulation therapy.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved., Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan
ong #50, Gangnam-gu, Seoul 135-710, South Korea. Tel.: þ82 2 3410 3461; fax: þ82 2 3410 0040.
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Superior Mesenteric Artery Dissection 573Introduction
Spontaneous isolated superior mesenteric artery dissection
(SISMAD) has been anecdotally reported as a rare cause of
acute abdominal pain.1e13 The increasing use of diagnostic
imaging studies in the management of patients with acute
abdominal pain has resulted in SISMAD being more recog-
nised in recent times. Although a few case series have
described the clinical course of SISMAD,14,15 the natural
course and optimal management of this rare disease have
not yet been firmly established.
Currently, spiral CT scan is the diagnostic test of choice
in patients suspected of SISMAD and the most commonly
used test when SISMAD is diagnosed incidentally. When
discovered, the treatment options for SISMAD have been
less uniform and range from conservative therapy6,7,13,15 to
endovascular1,5 or open surgical treatment.2e4,8,9,11,16
Additionally, with conservative treatment, there is no
consensus on the benefit of anti-thrombotic therapy. Some
patients need early aggressive treatment for SISMAD based
on their presentation. In this study, we attempted to
identify those patients who might benefit from interven-
tion. Specifically, we sought a correlation between
abdominal pain and CT angiogram findings, looking for
specific angiographic findings that indicated the need for
initial invasive treatment. These findings were also corre-
lated with clinical outcome.
Materials and Methods
During the 7-year period from July 2001 to June 2008, 32
patients with SISMAD were detected at a single tertiary care
university hospital. Of these, 19 patients were diagnosed at
our institution and 13 patients were referred from outside
hospitals.
SISMAD was diagnosed by the presence of the charac-
teristic superior mesenteric artery (SMA) wall dissection on
abdominal spiral CT angiography (Fig. 1). Patients with
concomitant aortic dissection or a recent history of blunt
abdominal trauma (nZ 1) or those who had undergoneFigure 1 A CT angiographic finding of spontaneous isolated supe
view of SISMAD. (B) Sagittal view of SISMAD on reconstructed CT aSMA catheterisation (nZ 1) or recent upper abdominal
surgery were excluded from this study. We prospectively
followed up the clinical features of these patients and the
follow-up CT images in the latter 25 patients and retro-
spectively reviewed the medical recordings and imaging in
seven patients who were diagnosed earlier during the
study period. The recorded clinical features include the
nature of abdominal pain (onset, duration, severity and
relation to meals) and the provoking event (overeating,
overdrinking and pancreatitis). Severity of abdominal pain
at initial presentation was graded 0e10 using a visual
analogue scale. The initial CT angiogram was assessed for
entry and re-entry points of the dissection, dissection
length, patency and degree of luminal stenosis at the
dissected segment of the SMA. To assess angiographic
features, both axial and reconstructed sagittal views of
contrast-enhanced spiral CT scans were independently
interpreted by two experienced attending radiologists.
Angiographic findings were categorised into three types
according to the presence of false luminal flow and true
lumen patency at the dissected segment (Table 1, Fig. 2).
Dissection entry sites were categorised into three zones,
namely: Zone 1, orifice to 1 cm proximal to the SMA
curvature; Zone 2, from 1 cm proximal to 1 cm distal to the
SMA curvature; and Zone 3, distal to 1 cm distal to the SMA
curvature. Conservative treatment consisted of bowel rest,
nasogastric suction, intravenous fluid therapy and paren-
teral nutritional support as required. During the earlier
part of this study, we used intravenous anticoagulation
therapy in five patients, but all subsequent patients
received neither anticoagulation nor anti-platelet therapy.
Surgical or endovascular interventions were performed for
suspected bowel infarction or severe, persistent abdominal
pain (nZ 4) despite maximal conservative treatment. All
patients were followed up on an outpatient basis (mean
26 months; range 1e80 months). During follow-up,
abdominal symptoms (recurrent or residual) were
assessed. CT angiograms were performed every 6 months
to look for evolution of SISMAD. Of the 32 patients, 28
(88%) were available for follow-up with CT angiogram
(mean 22 months; range 1e80 months).rior mesenteric artery dissection (SISMAD). (A) Cross-sectional
ngiography.
Table 1 Categorisation of angiographic findings of spon-
taneous isolated superior mesenteric artery dissection
(SISMAD).
Type Angiographic findings
Type I Patent true and false lumen revealing
entry and re-entry sites
Type II Patent true lumen but no re-entry flow
from the false lumen
Type IIa Visible false lumen but not visible re-entry
site (‘‘blind pouch of false lumen’’)
Type IIb Not visible false luminal flow (thrombosed
false lumen) which usually causes true
lumen narrowing
Type III SMA dissection with occlusion of SMA
574 W.S. Yun et al.Categorical variables are expressed as number and
percentage of patients. Comparisons between groups were
performed using cross-table methods with Fisher’s exact
test. Continuous variables are presented as median and
range values in case of a non-parametric distribution, and
comparisons were made using the ManneWhitney test. For
correlation analyses between abdominal pain severity and
angiographic type or pain severity and dissection length,
Spearman’s partial correlation analysis was conducted on
the 22 symptomatic patients. Statistical analysis was per-
formed with the SPSS software (SPSS version 12.0.1, SPSS
Inc., Chicago, IL, USA).
Results
The demographic and clinical features of the 32 patients
are shown in Table 2. Twenty-two (69%) patients presentedFigure 2 Angiographic categorisation of SISMAD based owith abdominal pain, whereas 10 patients were asymp-
tomatic and had their SISMAD discovered incidentally. In
these patients, there was no other abdominal symptom
attributable to SISMAD.
At presentation, SISMAD lesions were categorised into the
following groups according to their angiographic findings:
41% Type I, 50% Type II and 9%Type III. TheType I lesionswere
most common in incidentally discovered patients (seven of
10, 70%),whereas Type II lesionswere themost common type
in symptomatic patients (13 of 22, 59%). With regards to
dissection entry site, Zone 2 (SMA segment from 1 cm prox-
imal to 1 cm distal to the SMA curvature) was the most
common site of entry (22 of 32, 69%).
The median length of dissection was longer in the
symptomatic patients than in the incidentally detected
patients (64 mm, range 20e160 mm vs. 35 mm, range 23e
78 mm, pZ 0.04, by ManneWhitney test). When entry site
locations were categorised into three zones, no differences
were detected between symptomatic and incidentally
detected patients (pZ 0.16 by Fisher’s exact test). In the
22 symptomatic patients, pain severity scores showed
a positive correlation with SISMAD length (pZ 0.03 and
rZ 0.50 by Spearman’s partial correlation analysis, Fig. 3),
but not with angiographic type (pZ 0.07 by Spearman’s
partial correlation analysis).
Twenty-eight patients (including 10 asymptomatic
patients) underwent conservative treatment. In four
patients with severe and persistent abdominal pain, we
restored SMA flow as follows: two retrograde aorto-
mesenteric bypasses, one SMA thrombo-intimectomy with
patch closure and one SMA stenting (4  40 mm self-
expandable nitinol stent). None of those patients had bowel
gangrene at operation. Table 3 demonstrates the follow-up
results of the 32 patients.n cross-sectional and sagittal views of CT angiography.
Table 2 Patient demographic and clinical features.
Features (nZ 32) No. (%)
Mean age (range, years) 54 (33e85)
Gender, male (%) 31 (97)
Coexisting medical conditions
Smoking (current and ex-smoker) 12 (38)
Hypertension 10 (31)
Intraabdominal cancera 6 (19)
Diabetes mellitus 1 (3)
Ischaemic heart disease 1 (3)
Hypercholesterolaemia 4 (13)
Cerebrovascular disease 1 (3)
Abdominal aortic aneurysm 2 (6)
Marfan’s syndrome 1 (3)
Clinical manifestation
Incidentally detected 10 (31)
Pain 22 (69)
Onset mode
Sudden 21 (95)
Insidious 1 (5)
Location
Abdominal pain 19 (86)
Back pain 1 (5)
Abdominal and back pain 2 (9)
Severity scoreb
Mild (score, 1e3) 2 (9)
Moderate (score, 4e6) 2 (9)
Severe (score, 7e10) 18 (82)
Postprandial nature 6 (27)
Other symptoms
Nausea 5 (16)
Bloody stool 1 (3)
Diarrhoea 3 (9)
a Intraabdominal cancer: 4 colorectal cancer, 1 gastric cancer,
and 1 anal cancer.
b Pain severity score measured by visual analogue scale from
0 to 10.
Figure 3 Spearman’s partial correlation analysis of pain
severity scores and lengths of SMA dissections (nZ 22, symp-
tomatic patients).
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there was no difference in the clinical outcomes among
patients who received anticoagulation (nZ 5), anti-
platelet therapy (nZ 4) or treatment (nZ 19) (pZ 1.00,
Fisher’s exact test). Table 4 presents follow-up angio-
graphic results for 28 SISMAD patients treated conserva-
tively. In four patients, SISMAD healed completely, with
a median time to healing of 6 months (range 3e16 months).
Either anticoagulant or anti-platelet agent was given to one
patient each, and two patients did not receive any anti-
thrombic agent.
Discussion
Although spontaneous aortic dissection is a well-known and
common vascular disease, spontaneous dissection of
peripheral arteries is rare. Of the peripheral arteries, the
SMA is the second most common artery after the internal
carotid artery.5 Since Bauersfeld reported the first case of
SISMAD in 1947,17 treatment results for SISMAD patients
have been disparate. To our knowledge, the present report
constitutes the largest series of patients with SISMAD from
a single institution. Due to the rarity of this disease, the
underlying cause and the natural course of SISMAD have yet
to be determined.
In contrast to the well-known correlation between
hypertension and aortic dissection,18 hypertension was only
present in a third of our patient group. To explain the
underlying mechanism of SISMAD, Solis et al.16 focussed on
the location of the entry point of dissection, which is
usually located at 1.5e3 cm distal to the orifice of SMA. This
segment of the SMA is a transition zone of the SMA from
a fixed segment under the pancreas to the mobile segment
at the mesenteric root. This transition point could be the
focus of intimal tear due to abnormal sheering stress.
Subsequent to finding that all SISMAD entry points wereTable 3 Follow-up results after treatment of SISMAD
patients (nZ 32).
Treatment No.
(%)
Recurrent
symptom
(nZ 4,
13%)
Progressiona
of dissection
(nZ 0)
Surgical treatment 3 (9) 1 0
Aorto-SMA bypass 2 1 0
SMA thrombo-
intimectomy
1 0 0
SMA stenting 1 (3) 0 N-Ab
Conservative treatment 28 (88) 3c 0
Anti-platelet agent 4 1 0
Anticoagulation 5 0 0
No anti-thrombotic
medicationb
19 2 0
a Progression on the follow-up spiral CT angiography.
b SMA stent was occluded at 17 months after insertion but the
patient was free from bowel ischemic symptom for 31 months.
c Three patients with recurrent symptom include two patients
with postprandial abdominal discomfort and one patient
requiring segmental resection of ileum due to bowel stricture.
Table 4 Follow-up results of conservative treatment
(nZ 28a) according to the angiographic findings.
Angiographic
findings
No (%) Recurrent
abdominal
symptom
(nZ 3, 11%)
Healing of
dissection
(nZ 4, 14%)
Types of SISMADb
Type I 12 (43) 1 (33) 1 (25)
Type II 13 (46) 2 (67) 3 (75)
Type IIa 5 1 2
Type IIb 8 1 1
Type III 3 (11) 0 0
Location of entry sitec
Zone 1 1 (4) 0 0
Zone 2 18 (64) 3 (100) 2 (50)
Zone 3 9 (32) 0 2 (50)
Length of dissection
<40 mm 10 (36) 1 (33) 2 (50)
40e80 mm 12 (43) 2 (67) 1 (25)
>80 mm 6 (21) 0 1 (25)
a Twenty-eight patients who underwent conservative treat-
ment were included.
b Type of SISMAD: Type I, patent true and false lumen
revealing entry and re-entry sites; Type II, patent true lumen
but no flow through the false lumen; Type III, SMA dissection
with SMA occlusion.
c Location of entry site: Zone 1, SMA segment from the orifice
to 1 cm proximal to the SMA curvature; Zone 2, SMA segment
from 1 cm proximal to 1 cm distal to the SMA curvature; Zone 3,
distal to Zone 2.
576 W.S. Yun et al.located near the curvature of the SMA, we hypothesised
that the convex-curved run of the SMA might provide an
additional mechanical factor that initiates SMA dissection.
Recently, Hashimoto et al.19 reported a case of acute SMA
dissection in a patient who had pathologically proven
segmental arterial mediolysis. There is a changing trend in
treatment of SISMAD from open surgical treatment2e4,8,9,11,16
which was favoured in earlier days over SMA stenting1,5 or
conservative treatment.6,7,12,13,15 Previous recommendation
for treatment of SISMAD was based on experiences with
a limited number of patients and short-term follow-up.
Various surgical techniques have been described for
treatment of SISMAD, including aorto-mesenteric bypass,2,3
thrombo-intimectomy with optional patch angioplasty,2,4,16
endo-aneurysmorrhaphy,2,9 SMA interposition8 and right
gastro-epiploic artery-to-SMA bypass.11 In the early part of
this study, we performed two aorto-SMA bypasses and one
SMA thrombo-intimectomy for patients having persistent
abdominal pain. Given the limitations of a retrospective
review, the need for open surgery cannot be justified.
Some authors have reported stent placement in the SMA
for SISMAD treatment,1,5 and concluded that this modality
is a safe and feasible therapeutic option, but its long-term
results have yet to be determined. In our series, one
patient underwent stent placement which was found to be
occluded at 17 months; however, the patient remained free
from ischaemic bowel symptom at 31 months follow-up.
Recently, favourable outcomes have been reported by
many authors following conservative treatment.13e15Considering pain severity as a key factor in the decision-
making algorithm in terms of determining the need for
intervention in patients with an acute abdomen, we
attempted to identify any correlation between pain
severity and arteriographic type of SISMAD. Sakamoto
et al.15 categorised SISMAD into four types based on imaging
appearances. They did not include total thrombotic occlu-
sion of SMA trunk in their classification. Total thrombotic
occlusion due to SISMAD can be missed if incorrectly iden-
tified as SMA thrombosis. In the present study, SMA
dissection as an underlying cause of total occlusion of the
SMA trunk was detected by reviewing prior imaging studies
(contrast abdominal CT scan) performed at other institu-
tions before the patient was referred to us. In our study,
there was no correlation between arteriographic type and
pain severity; however, there was a positive correlation
between pain severity and dissection length even though
the correlation is weak. Some authors describe an inflam-
matory response around the arterial dissection, which
stimulates the visceral nerve plexus, thus inducing pain.20 It
seems logical that longer dissections would cause more
inflammation, and thus pain.
To determine whether abdominal pain could be attrib-
uted to bowel ischaemia, we investigated the frequency of
postprandial pain. This was present in only 27% of the 22
symptomatic patients. Moreover, in the majority of
patients, pain subsided spontaneously after a mean dura-
tion of 3.5 days of conservative treatment. From these
observations, we believe that most abdominal pain in
SISMAD patients was not derived from bowel ischaemia.
In terms of anticoagulation therapy in SISMAD, some
authors have advocated its use6,7 to prevent thrombus
propagation, while others have not.12,14 The argument for
anticoagulation therapy is based on early case reports
before the 1970s in which SISMAD patients developed bowel
necrosis when treated conservatively without anti-
coagulation therapy. However, there has been no firm
evidence to support anticoagulation therapy in SISMAD. In
patients with spontaneous dissection of the carotid artery,
anticoagulation has usually been prescribed to prevent
secondary thrombosis of distal intracranial arterial bed.
Anticoagulation can prevent false lumen thrombosis at
the dissected SMA, and thus promote further propagation of
dissection. During the early period of this study, we
routinely used anticoagulant therapy, but discontinued its
use when we noticed that patients referred from other
hospitals without anticoagulation therapy had no differ-
ence in their clinical outcomes. Furthermore, we did not
appreciate a difference in outcome with use of anticoagu-
lants or anti-platelet agents for SISMAD patients.
During follow-up, no patient had lesion progression on
spiral CT scans, except for one who had mild dilatation of
SMA at the anastomosis site between polytetrafluoro-
ethylene (PTFE) graft and thrombo-intimectomised SMA.
Recently, Takayama et al.14 reported their series of
isolated spontaneous dissection of the splanchnic arteries
including 11 SISMAD. According to their observation, they
also found no expansion or progression of the false lumen
after follow-up of 21 months (2e116 months). We found
that recurrent abdominal symptoms developed in four (18%)
patients who initially presented with pain, but no late pain
developed in 10 patients who were incidentally detected.
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further treatment was required.
Given the low sample size, we were unable to perform
a statistical analysis to find a correlation between angio-
graphic findings and late clinical outcomes. No patients had
recurrent symptoms, including those with Type III SISMAD
lesions. We interpret this as development of collateral
circulation during gradual thrombotic occlusion of the SMA.
Considering that SISMAD can be underestimated, there
should be a high index of suspicion for SISMAD when SMA
thrombosis is discovered in middle-aged men.
In summary, we found that SISMAD occurs mainly in male
patients in their fifth decade. Furthermore, the underlying
causes of SISMAD did not appear to be related to athero-
sclerotic risk factors such as hypertension. In patients with
SISMAD, after conservative treatment, we observed
a benign clinical course, even without anticoagulation or
anti-platelet use. No progression of dissection was observed
on follow-up CT. For patients without signs of acute bowel
ischaemia or SMA rupture, we recommend conservative
treatment without anticoagulation therapy as first-line
treatment. Though we did not find any relation between
angiographic appearance and clinical course in the present
study, we suggest that further prospective investigations be
conducted in SISMAD patients to establish optimal
management plans based on angiographic findings.
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